U-Blot® Research Grade GemtuzumabCat. No. WA2908$9,999
Size: 50ug/100ug
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade GemtuzumabCat. No. WA2908
U-Blot® Research Grade GefurulimabCat. No. WA2907
U-Blot® Research Grade GedivumabCat. No. WA2906
U-Blot® Research Grade GavilimomabCat. No. WA2905
U-Blot® Research Grade GatralimabCat. No. WA2904
U-Blot® Research Grade GatipotuzumabCat. No. WA2903
U-Blot® Research Grade gaspantatugCat. No. WA2902
U-Blot® Research Grade GarivulimabCat. No. WA2901
U-Blot® Research Grade GaretosmabCat. No. WA2900
U-Blot® Research Grade garetatugCat. No. WA2899
U-Blot® Research Grade GaradacimabCat. No. WA2898
U-Blot® Research Grade GantenerumabCat. No. WA2897